Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Sales (2016 - 2025)

Historic Return on Sales for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 0.34%.

  • Ekso Bionics Holdings' Return on Sales rose 3200.0% to 0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.6% for FY2024, which is 2400.0% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Return on Sales stood at 0.34% for Q3 2025, which was up 3200.0% from 1.96% recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Return on Sales ranged from a high of 0.34% in Q3 2025 and a low of 1.96% during Q2 2025
  • Over the past 5 years, Ekso Bionics Holdings' median Return on Sales value was 0.98% (recorded in 2022), while the average stood at 1.02%.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Return on Sales surged by 16400bps in 2021, and later tumbled by -14800bps in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Return on Sales (Quarter) stood at 1.13% in 2021, then dropped by -13bps to 1.27% in 2022, then surged by 43bps to 0.73% in 2023, then skyrocketed by 38bps to 0.45% in 2024, then grew by 25bps to 0.34% in 2025.
  • Its Return on Sales was 0.34% in Q3 2025, compared to 1.96% in Q2 2025 and 1.04% in Q1 2025.